Continuous subcutaneous insulin infusion. American Diabetes Association.
Use of continuous subcutaneous insulin infusion requires continuing available care by skilled professionals, careful selection of patients, meticulous patient monitoring, and provisions for recording and reporting experiences. Insulin pumps prescribed by a physician within these guidelines are a part of treatment and should be covered by usual payment mechanisms.
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D006801:Humans; D007332:Insulin Infusion Systems / Q000009:adverse effects; D012449:Safety